MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $671,509 | -35.1% | 204,106 | -18.9% | 0.00% | -50.0% |
| Q1 2023 | $1,034,882 | +104.4% | 251,796 | +191.5% | 0.00% | +33.3% |
| Q4 2022 | $506,222 | +36.1% | 86,386 | +56.8% | 0.00% | +50.0% |
| Q3 2022 | $372,000 | +247.7% | 55,089 | +138.2% | 0.00% | +100.0% |
| Q2 2022 | $107,000 | -91.0% | 23,126 | -92.3% | 0.00% | -90.0% |
| Q1 2022 | $1,195,000 | +232.9% | 299,454 | +418.5% | 0.01% | +233.3% |
| Q4 2021 | $359,000 | -57.8% | 57,757 | -7.9% | 0.00% | -70.0% |
| Q2 2021 | $851,000 | – | 62,685 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |